Keyphrases
Clinical Trials
100%
Core Outcome Set
87%
Risk-benefit
64%
Patient Outcomes
62%
Drug Development
60%
Risk Outcomes
59%
Patient Benefit
59%
Patient Risk
59%
Reporting Guidelines
48%
Randomized Controlled Trial
45%
Clinical Trial Registry
41%
Sectional Analysis
37%
Web-based Survey
21%
Trialists
20%
Adverse Events
19%
Malawi
15%
Behavioral Risk Factor Surveillance System (BRFSS)
15%
Oklahoma
15%
Cost-plus
13%
Cuban
13%
Drug Companies
13%
Clinical Perspective
13%
FDA-approved Drugs
13%
Objective Response Rate
13%
United States
13%
Trial Registration
13%
Overall Survival
13%
Medicare
12%
Africa
12%
Type I Diabetes
11%
Type 1 Diabetes Mellitus (T1DM)
10%
Chronic Kidney Disease
10%
Public Interest
10%
Ramucirumab
10%
Comorbidity
10%
Search Interest
9%
Adverse childhood Experiences
9%
Approved Indication
9%
Instructions to Authors
8%
Mental Health
8%
Staff Members
8%
Trial Characteristics
8%
PubMed
8%
Caregivers
8%
Scopus
7%
Embase
7%
Cancer Clinical Trials
7%
Health Research
7%
Progression-free Survival
7%
Cochrane
7%
CiteScore
7%
Quality Improvement Project
7%
Inflammatory Bowel Disease
6%
Olaparib
6%
Stroke Trials
6%
Parkinson's Disease
6%
Childrens
6%
Home Health Care
6%
Youth Risk Behavior Surveillance System
6%
Meta-epidemiological Study
6%
National Survey
6%
Immune Thrombocytopenic Purpura
6%
Depression Prevalence
6%
Resilience
6%
Hyperdense Artery Sign
6%
Acute Cerebral Ischemia
6%
Google Search
6%
Sudden Infant Death Syndrome
6%
Provider Education
6%
Hip Osteoarthritis
6%
Knee Osteoarthritis
6%
Lenvatinib
6%
Regorafenib
6%
Afatinib
6%
Nephrology
6%
Family-centered Care
6%
Sickle Cell Disease
6%
Social Connection
6%
Exercise Goals
6%
Top 100
6%
Median Progression-free Survival
6%
Infectious Diseases
6%
Research Quality
6%
Data Extraction
6%
Descriptive Statistics
6%
Diabetes
6%
Frequently Asked Questions
6%
Ovarian Cancer
6%
Lung Cancer
6%
PRISMA
6%
Care Recipient
6%
Medical Journals
6%
Inclusion Criteria
5%
MEDLINE
5%
Research Electronic Data Capture (REDCap)
5%
Breast Cancer
5%
Consolidated Standards of Reporting Trials (CONSORT)
5%
Inferential Statistics
5%
Off-label Indications
5%
Prostate Cancer
5%
Medicine and Dentistry
Clinical Trial
87%
Cross Sectional Study
52%
Randomized Controlled Trial
34%
Systematic Review
28%
Prevalence
19%
Behavioral Risk Factor Surveillance System
13%
Mental Health
12%
American Indian
11%
Chronic Kidney Disease
10%
Emergency Department
10%
Adverse Event
10%
Ramucirumab
10%
Disease
9%
Apoplexy
9%
Patient Care
9%
Computer Assisted Tomography
9%
Malignant Neoplasm
8%
Overall Survival
7%
Drug Therapy
7%
Health Outcomes
7%
Meta-Analysis
7%
COVID-19
7%
Health Care Cost
7%
Olaparib
6%
Parkinson's Disease
6%
Home Health Care
6%
Medicare
6%
Brain Ischemia
6%
Middle Cerebral Artery
6%
Substance Use Disorder
6%
Idiopathic Thrombocytopenic Purpura
6%
Lung Cancer
6%
Osteoarthritis
6%
Nephrology
6%
Family Practice
6%
Family Centered Care
6%
Awareness
6%
Hip Osteoarthritis
6%
Clinician
6%
Student T Test
5%
Progression Free Survival
5%
Diabetes
5%
Inferential Statistics
5%
Ovarian Cancer
5%
Diagnosis of Depression
5%
Knee Osteoarthritis
5%
Quality of Life
5%